Evidence map›Paper›PMID 28192563›Full record

ArticleJAMA internal medicine2017

Evaluation of Evidence of Statistical Support and Corroboration of Subgroup Claims in Randomized Clinical Trials.

Joshua D Wallach, Patrick G Sullivan, John F Trepanowski, Kristin L Sainani, Ewout W Steyerberg, John P A Ioannidis

Abstract read
In one paragraph

Article in JAMA internal medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The credibility of subgroup analyses reported in stroke trials is low: A systematic review.International journal of stroke : official journal of the International Stroke Society · 2023
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Review
  17. Review
  18. Heterogeneity in associations between food insecurity and diabetes outcomes.Journal of epidemiology and community health · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Joshua D WallachDepartment of Health Research and Policy, Stanford University School of Medicine, Stanford, California2Meta-Research Innovation Center at Stanford (METRICS), Stanford University School of Medicine, Stanford, California.
Patrick G SullivanDepartment of Health Research and Policy, Stanford University School of Medicine, Stanford, California2Meta-Research Innovation Center at Stanford (METRICS), Stanford University School of Medicine, Stanford, California3Department of Medicine, Stanford University School of Medicine, Stanford, California.
John F TrepanowskiStanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, California.
Kristin L SainaniDepartment of Health Research and Policy, Stanford University School of Medicine, Stanford, California.
Ewout W SteyerbergDepartment of Public Health, Erasmus MC, Rotterdam, the Netherlands.
John P A IoannidisDepartment of Health Research and Policy, Stanford University School of Medicine, Stanford, California2Meta-Research Innovation Center at Stanford (METRICS), Stanford University School of Medicine, Stanford, California3Department of Medicine, Stanford University School of Medicine, Stanford, California4Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, California6Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, California.

Funding

Spectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1M
CARDIOVASCULAR DISEASE PREVENTION TRAINING PROGRAMT32HL007034 · NHLBI · STANFORD UNIVERSITY · PI GARDNER, CHRISTOPHER D · 1985 to 2020
$8.7M
Value of Personalized Risk InformationU01NS086294 · NINDS · TUFTS MEDICAL CENTER · PI KENT, DAVID M, NEUMANN, PETER · 2013 to 2017
$2.6M
NCATS NIH HHS UL1 TR001085NHLBI NIH HHS T32 HL007034NINDS NIH HHS U01 NS086294
6 · The paper itself

Abstract

Importance: Many published randomized clinical trials (RCTs) make claims for subgroup differences. Objective: To evaluate how often subgroup claims reported in the abstracts of RCTs are actually supported by statistical evidence (P < .05 from an interaction test) and corroborated by subsequent RCTs and meta-analyses. Data Sources: This meta-epidemiological survey examines data sets of trials with at least 1 subgroup claim, including Subgroup Analysis of Trials Is Rarely Easy (SATIRE) articles and Discontinuation of Randomized Trials (DISCO) articles. We used Scopus (updated July 2016) to search for English-language articles citing each of the eligible index articles with at least 1 subgroup finding in the abstract. Study Selection: Articles with a subgroup claim in the abstract with or without evidence of statistical heterogeneity (P < .05 from an interaction test) in the text and articles attempting to corroborate the subgroup findings. Data Extraction and Synthesis: Study characteristics of trials with at least 1 subgroup claim in the abstract were recorded. Two reviewers extracted the data necessary to calculate subgroup-level effect sizes, standard errors, and the P values for interaction. For individual RCTs and meta-analyses that attempted to corroborate the subgroup findings from the index articles, trial characteristics were extracted. Cochran Q test was used to reevaluate heterogeneity with the data from all available trials. Main Outcomes and Measures: The number of subgroup claims in the abstracts of RCTs, the number of subgroup claims in the abstracts of RCTs with statistical support (subgroup findings), and the number of subgroup findings corroborated by subsequent RCTs and meta-analyses. Results: Sixty-four eligible RCTs made a total of 117 subgroup claims in their abstracts. Of these 117 claims, only 46 (39.3%) in 33 articles had evidence of statistically significant heterogeneity from a test for interaction. In addition, out of these 46 subgroup findings, only 16 (34.8%) ensured balance between randomization groups within the subgroups (eg, through stratified randomization), 13 (28.3%) entailed a prespecified subgroup analysis, and 1 (2.2%) was adjusted for multiple testing. Only 5 (10.9%) of the 46 subgroup findings had at least 1 subsequent pure corroboration attempt by a meta-analysis or an RCT. In all 5 cases, the corroboration attempts found no evidence of a statistically significant subgroup effect. In addition, all effect sizes from meta-analyses were attenuated toward the null. Conclusions and Relevance: A minority of subgroup claims made in the abstracts of RCTs are supported by their own data (ie, a significant interaction effect). For those that have statistical support (P < .05 from an interaction test), most fail to meet other best practices for subgroup tests, including prespecification, stratified randomization, and adjustment for multiple testing. Attempts to corroborate statistically significant subgroup differences are rare; when done, the initially observed subgroup differences are not reproduced.

Indexed as

Evidence-Based MedicineRandomized Controlled Trials as TopicData Interpretation, StatisticalDiagnosis-Related GroupsHumansIntention to Treat AnalysisPublishing

Identifiers

PMID28192563
PMCPMC6657347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.